CLINICAL RELEVANCE OF TRANSFORMING-GROWTH-FACTOR-ALPHA, EPIDERMAL GROWTH-FACTOR RECEPTOR, P53, AND KI67 IN COLORECTAL LIVER METASTASES AND CORRESPONDING PRIMARY TUMORS
Kp. Dejong et al., CLINICAL RELEVANCE OF TRANSFORMING-GROWTH-FACTOR-ALPHA, EPIDERMAL GROWTH-FACTOR RECEPTOR, P53, AND KI67 IN COLORECTAL LIVER METASTASES AND CORRESPONDING PRIMARY TUMORS, Hepatology, 28(4), 1998, pp. 971-979
To determine whether the expression of transforming growth factor alph
a (TGF-alpha), its receptor (epidermal growth factor receptor [EGFr]),
p53 nuclear protein, and proliferation influences prognosis of patien
ts with liver metastases, a study was performed in 45 liver metastases
and 33 corresponding primary colorectal carcinomas in patients referr
ed for liver surgery. The expression of TGF-alpha, EGFr, p53 nuclear p
rotein, and proliferation rate was correlated with clinicopathological
characteristics and survival after partial liver resection, In liver
metastases, TGF-alpha expression was low in 42%, intermediate in 35%,
and high in 23%, TGF-alpha expression was higher in liver metastases d
erived from lymph node-positive primary carcinomas, in synchronous and
in irresectable liver metastases compared with those derived from lym
ph node-negative primary carcinomas, metachronous, and resectable live
r metastases, Nuclear p53 expression was found in 83% of primary tumor
s and 71% of liver metastases. p53 expression did not correlate with t
he various clinicopathological characteristics. Ki67 expression was no
t associated with clinicopathological characteristics in primary and m
etastatic tumors, In the 38 patients in whom a partial liver resection
was performed, median survival was 25 months in patients with a highe
r TGF-alpha expression in the metastasis than in the primary tumor and
60 months in patients with comparable or lower TGF-alpha expression i
n the metastasis than in the primary tumor (P = .036), Median survival
after liver resection was 21 months in patients with p53-negative liv
er metastases and 58 months in patients with p53-positive metastases (
P = .043). By multivariate analysis, p53 and EGFr expression on liver
metastases were the best predictors of disease-free survival after par
tial liver resection, with relative risks of 2.38 and 3.33, respective
ly. In patients with colorectal liver metastases, referred for liver s
urgery, a higher TGF-alpha expression is associated with unfavorable t
umor characteristics, whereas p53 and absence of EGFr expression is as
sociated with a better survival after partial liver resection.